Fiduciary Group LLC Bristol Myers Squibb CO Transaction History

Fiduciary Group LLC

  • $975 Million
  • Q1 2025

A detailed history of Fiduciary Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fiduciary Group LLC holds 20,372 shares of BMY stock, worth $936,093. This represents 0.13% of its overall portfolio holdings.

Number of Shares
20,372
Previous 20,872 2.4%
Holding current value
$936,093
Previous $1.18 Million 5.25%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
SELL
$53.9 - $63.11 $26,950 - $31,555
-500 Reduced 2.4%
20,372 $1.24 Million
Q4 2024

Feb 11, 2025
SELL
$51.92 - $59.94 $149,166 - $172,207
-2,873 Reduced 12.1%
20,872 $1.18 Million
Q3 2024

Nov 13, 2024
SELL
$39.66 - $51.75 $58,736 - $76,641
-1,481 Reduced 5.87%
23,745 $1.23 Million
Q2 2024

Aug 08, 2024
SELL
$40.25 - $52.99 $112,579 - $148,213
-2,797 Reduced 9.98%
25,226 $1.05 Million
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $13,578 - $15,395
-283 Reduced 1.0%
28,023 $1.52 Million
Q4 2023

Feb 05, 2024
SELL
$48.48 - $57.85 $54,830 - $65,428
-1,131 Reduced 3.84%
28,306 $1.45 Million
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $18,698 - $20,907
-323 Reduced 1.09%
29,437 $1.71 Million
Q2 2023

Jul 27, 2023
BUY
$63.71 - $70.74 $5,606 - $6,225
88 Added 0.3%
29,760 $1.9 Million
Q1 2023

May 15, 2023
SELL
$65.71 - $74.53 $11,630 - $13,191
-177 Reduced 0.59%
29,672 $2.06 Million
Q4 2022

Feb 07, 2023
SELL
$68.48 - $81.09 $58,618 - $69,413
-856 Reduced 2.79%
29,849 $2.15 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $67 - $39,956
520 Added 1.72%
30,705 $2.44 Million
Q2 2022

Aug 12, 2022
BUY
$72.62 - $79.98 $226,066 - $248,977
3,113 Added 11.5%
30,185 $2.32 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $5,102 - $6,118
83 Added 0.31%
27,072 $2.06 Million
Q3 2021

Oct 27, 2021
SELL
$59.17 - $69.31 $31,064 - $36,387
-525 Reduced 1.91%
26,989 $1.57 Million
Q2 2021

Aug 05, 2021
SELL
$61.91 - $67.42 $13,929 - $15,169
-225 Reduced 0.81%
27,514 $1.88 Million
Q1 2021

May 03, 2021
SELL
$59.34 - $66.74 $17,802 - $20,022
-300 Reduced 1.07%
27,739 $1.73 Million
Q4 2020

Feb 12, 2021
SELL
$57.74 - $65.43 $7,332 - $8,309
-127 Reduced 0.45%
28,039 $1.68 Million
Q2 2020

Aug 14, 2020
SELL
$54.82 - $64.09 $29,876 - $34,929
-545 Reduced 1.9%
28,166 $1.66 Million
Q1 2020

May 11, 2020
SELL
$46.4 - $67.43 $30,624 - $44,503
-660 Reduced 2.25%
28,711 $1.6 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $16,239 - $21,182
330 Added 1.14%
29,371 $1.89 Million
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $22,283 - $26,419
-521 Reduced 1.76%
29,041 $1.47 Million
Q2 2019

Aug 05, 2019
SELL
$44.62 - $49.34 $16,375 - $18,107
-367 Reduced 1.23%
29,562 $1.34 Million
Q1 2019

May 08, 2019
SELL
$45.12 - $53.8 $36,096 - $43,040
-800 Reduced 2.6%
29,929 $1.43 Million
Q4 2018

Feb 13, 2019
SELL
$48.76 - $63.23 $109,222 - $141,635
-2,240 Reduced 6.79%
30,729 $1.6 Million
Q3 2018

Oct 18, 2018
BUY
$55.19 - $62.25 $229,038 - $258,337
4,150 Added 14.4%
32,969 $2.05 Million
Q2 2018

Aug 02, 2018
SELL
$50.53 - $62.98 $118,745 - $148,003
-2,350 Reduced 7.54%
28,819 $1.6 Million
Q1 2018

May 14, 2018
SELL
$59.92 - $68.98 $90,479 - $104,159
-1,510 Reduced 4.62%
31,169 $1.97 Million
Q4 2017

Feb 02, 2018
SELL
$59.94 - $65.35 $36,263 - $39,536
-605 Reduced 1.82%
32,679 $2 Million
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $1.84 Million - $2.12 Million
33,284
33,284 $2.12 Million

Others Institutions Holding BMY

# of Institutions
2,677
Shares Held
1.58B
Call Options Held
25.9M
Put Options Held
24.1M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $97.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email